O
Our business

Press releases

#
27 Mar 2014

Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate

read more
#
24 May 2012

Synthon obtains European approvals for zoledronic acid

read more
#
16 Apr 2012

Synthon receives tentative approval for tadalafil tablets

read more
#
05 Apr 2012

Synthon sued for infringing certain patents for Copaxone®

read more
#
19 Jan 2012

Synthon receives European approvals for rosuvastatin

read more
#
02 Jan 2012

Synthon obtains European approvals for ibandronate injectable

read more
#
13 Dec 2011

Synthon filed glatiramer acetate dossier in the U.S.

read more
#
01 Nov 2011

Synthon announces European approvals for eplerenone

read more
#
05 Jul 2011

Synthon obtains European approvals for two levetiracetam products

read more
     Share this page
Archive